Crispr Therapeutics Ag Stock Momentum Indicators Absolute Price Oscillator

CRSP Stock  USD 47.88  1.59  3.43%   
Crispr Therapeutics momentum indicators tool provides the execution environment for running the Absolute Price Oscillator indicator and other technical functions against Crispr Therapeutics. Crispr Therapeutics value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of momentum indicators indicators. As with most other technical indicators, the Absolute Price Oscillator indicator function is designed to identify and follow existing trends. Momentum indicators of Crispr Therapeutics are pattern recognition functions that provide distinct formation on Crispr Therapeutics potential trading signals or future price movement. Analysts can use these trading signals to identify current and future trends and trend reversals to provide buy and sell recommendations. Please specify Fast Period, Slow Period and MA Type to execute this model.

The output start index for this execution was twenty-five with a total number of output elements of thirty-six. Crispr Therapeutics Absolute Price Oscillator shows the difference between two moving averages. A buy signal of Crispr Therapeutics is generate when the Price Oscillator rises above zero, and a sell signal when it falls below zero.

Crispr Therapeutics Technical Analysis Modules

Most technical analysis of Crispr Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Crispr from various momentum indicators to cycle indicators. When you analyze Crispr charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Crispr Therapeutics Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Crispr Therapeutics AG. We use our internally-developed statistical techniques to arrive at the intrinsic value of Crispr Therapeutics AG based on widely used predictive technical indicators. In general, we focus on analyzing Crispr Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Crispr Therapeutics's daily price indicators and compare them against related drivers, such as momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Crispr Therapeutics's intrinsic value. In addition to deriving basic predictive indicators for Crispr Therapeutics, we also check how macroeconomic factors affect Crispr Therapeutics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2021 2022 2023 2024 (projected)
Graham Number59.4567.3732.224.66
Receivables Turnover3.0K1.861.671.59
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Crispr Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
45.1047.8850.66
Details
Intrinsic
Valuation
LowRealHigh
43.0955.6758.45
Details
Naive
Forecast
LowNextHigh
42.0744.8547.62
Details
29 Analysts
Consensus
LowTargetHigh
80.2088.1397.82
Details

Become your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Did you try this?

Run Instant Ratings Now

   

Instant Ratings

Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
All  Next Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Entertainment Idea
Entertainment
Invested over 90 shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Momentum Idea
Momentum
Invested over 60 shares
Hedge Favorites Idea
Hedge Favorites
Invested over 100 shares
Banking Idea
Banking
Invested over 20 shares
Artificial Intelligence Idea
Artificial Intelligence
Invested few shares
Social Domain Idea
Social Domain
Invested few shares
Dividend Beast Idea
Dividend Beast
Invested over 50 shares
Macroaxis Picks Idea
Macroaxis Picks
Invested over 30 shares
Manufacturing Idea
Manufacturing
Invested over 30 shares

Additional Tools for Crispr Stock Analysis

When running Crispr Therapeutics' price analysis, check to measure Crispr Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Crispr Therapeutics is operating at the current time. Most of Crispr Therapeutics' value examination focuses on studying past and present price action to predict the probability of Crispr Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Crispr Therapeutics' price. Additionally, you may evaluate how the addition of Crispr Therapeutics to your portfolios can decrease your overall portfolio volatility.